The longevity supplement market has expanded faster than the underlying evidence. Most "best longevity supplements" lists are vendor-led; the products linked are usually the linker's own brand of each compound. This guide is vendor-agnostic. The recommendations are sourced from compound-level evidence on biox compound pages, ranked by replicated human trial data, not by sponsorship.
What "longevity supplement" actually means
Two distinct framings show up in this category:
1. Healthspan extension: extending the duration of healthy, functional life rather than chronological lifespan. Most "longevity supplement" claims are healthspan claims, even when they imply lifespan. Healthspan is measurable via biomarkers, function tests, and disease incidence in cohort data.
2. Lifespan extension: actually prolonging chronological years lived. This is much harder to demonstrate; the trials required are decades-long with thousands of participants. No supplement has decisively shown lifespan extension in completed human RCTs.
Most legitimate longevity-supplement evidence is healthspan-flavored: improving biomarkers, reducing event rates, preserving function. The lifespan-extension claim is mostly mouse-data extrapolation.
Tier-A foundation: the boring four
These four supplements have the deepest human evidence base, broadest applicability, and lowest cost-per-effect ratio. They form the foundation under any longevity-focused supplement strategy.
Omega-3 EPA/DHA at 2-3 g/day combined. REDUCE-IT (Bhatt 2019, n=8,179) showed icosapent ethyl 4 g/day cut major cardiovascular events 25% in hypertriglyceridemic high-risk patients Bhatt et al. (REDUCE-IT) 2019, n=8179 . Outside the high-risk population, omega-3 reduces triglycerides 15-30%, contributes to brain phospholipid composition, and has cohort-level mortality associations. Triglyceride form is more bioavailable than ethyl ester. See the omega-3 EPA/DHA post.
Vitamin D3 + K2 at 5,000 IU + 100 mcg MK-7 daily. Covers bone, immune, and metabolic outcomes for adults with limited sun exposure. Adding K2 directs calcium to bone rather than arterial wall. Test 25-OH vitamin D annually; target 30-60 ng/mL serum. See the vitamin D + K2 stack post.
Magnesium glycinate at 200-400 mg/day. Addresses the common dietary inadequacy and supports sleep onset, blood pressure modulation, and insulin sensitivity. The glycinate form is well-absorbed without GI side effects of cheaper magnesium oxide.
Creatine monohydrate at 5 g/day. The most-replicated supplement in human research. Kreider 2017 ISSN position stand summarizes the evidence base across hundreds of trials Kreider et al. 2017 . Beyond muscle effects, growing cognitive evidence under sleep deprivation and aging cohorts. See the creatine living review.
These four cost roughly 30-50 dollars per month at quality brands. They cover the bulk of supplement-leveraged longevity effects. Most adults adding more compounds beyond this layer should think hard about marginal benefit.
Tier-B layer: moderate evidence for specific contexts
Compounds with replicated trial data and meaningful effect sizes for specific populations or goals.
Berberine at 1,500 mg/day divided for users with metabolic risk (elevated fasting glucose, family history of T2D, prediabetic HbA1c). Comparable glycemic effect to low-dose metformin in pre-diabetic adults; activates AMPK and lowers fasting glucose 5-15%.
Urolithin-A at 250-500 mg/day for users wanting mitochondrial-support layer. Andreux 2019 (n=60) demonstrated safety and mitophagy induction in skeletal muscle.
Spermidine at 1-6 mg/day for users wanting autophagy-axis support. Largest human safety database in the senolytic-adjacent class. Eisenberg 2016 cardiovascular cohort signal is encouraging but observational.
TUDCA at 250-500 mg/day for users with liver-related concerns or in the longevity stack for ER-stress modulation. Decades of pharmaceutical use in cholestasis at higher doses.
Coenzyme Q10 at 100-200 mg/day particularly for adults on statins. Modest exercise-tolerance and cardiovascular signals.
Nattokinase at 100-200 mg/day for cardiovascular support, particularly post-COVID concerns about microclot pathology. Small trials; emerging signal.
This layer adds 50-150 dollars per month depending on selections. Pick 1-3 compounds for specific goals rather than stacking the entire layer.
Tier-C experimental: weak human evidence at hard outcomes
Mechanistically interesting compounds with smaller human evidence base. Worth considering only after Tier-A and Tier-B are dialed in.
NMN and NR at 250-500 mg/day. Both raise plasma NAD+ reliably; surrogate biomarkers (insulin sensitivity, blood pressure) shift modestly. Hard outcomes absent. See NR vs NMN for the comparison detail.
Fisetin at the Mayo pulsed protocol (20 mg/kg for 2 days monthly). Senolytic case rests on Hickson 2019 (n=10) Hickson LJ et al 2019 . See senolytic supplements.
Rapamycin at 5-7 mg weekly (prescription). Strongest preclinical longevity case in this class. Off-label human use lacks long-horizon safety data. Specialist prescribers required.
Resveratrol at 500-2,000 mg/day. The original Sinclair-Sirtris program rested on misread cell-culture potency. Modern human trials report inconsistent metabolic effects.
Quercetin, EGCG, sulforaphane at typical supplement doses. Polyphenol mechanisms are real; oral concentrations rarely reach the cell-culture activation thresholds.
This layer adds 100-300 dollars per month depending on selections. The benefit beyond Tier-A and Tier-B is the open question of contemporary longevity supplementation.
Skip list: marketed as longevity, weak evidence
A roughly equal-length list of compounds widely sold in this category with disproportionately weak human evidence at typical doses.
- Multi-ingredient "anti-aging blends" (8-12 ingredients at sub-clinical doses)
- Proprietary stacks (Athletic Greens, Bryan Johnson's Blueprint stack) at 100-500 dollars per month with sub-clinical per-ingredient dosing
- High-dose collagen peptides for joint / skin healthspan (modest signal; protein intake from food matters more)
- CBD at retail doses (15-25 mg; effective doses are 100-600 mg)
- Greens powders as multivitamin substitutes (whole vegetables not bioequivalent to powdered concentrates)
- Polyphenol mega-stacks (resveratrol + quercetin + curcumin + EGCG simultaneously; marketing win, weak human evidence)
- NAD+ "boosters" with niacin or nicotinamide marketed as NMN/NR alternatives (real but cheaper; without the targeted-precursor case)
- TA-65 / cycloastragenol (telomerase activator with thin trial evidence and theoretical cancer concerns)
- Most "testosterone booster" blends at retail doses (ineffective at typical doses)
- Daily senolytic mega-doses (continuous high-dose fisetin / quercetin; senolytic biology is hit-and-run, not chronic-grind)
Practical 90-day starter sequence
For users new to evidence-led longevity supplementation:
Days 0-30, Foundation only: Tier-A four (creatine, omega-3, vitamin D3+K2, magnesium glycinate). Order baseline bloodwork (ApoB, HbA1c, hsCRP, vitamin D, ferritin, fasting glucose, fasting insulin). No other supplements.
Days 31-60, Tier-B selective: Add 1-2 compounds for specific goals. Berberine if elevated fasting glucose; spermidine for autophagy axis; CoQ10 if on statins. Run 4-week trial; assess subjective and objective markers.
Days 61-90, Tier-C optional: If foundation is dialed in and bloodwork is favorable, consider one Tier-C compound. Most defensible: spermidine continuous, urolithin-A continuous, or pulsed fisetin. Skip rapamycin without specialist prescriber.
Re-test bloodwork at 90 days. Adjust based on what changed. This is the supplement equivalent of a disciplined n=1 trial.
What actually moves the longevity needle
Behavior > supplements at every effect-size level:
- Sleep 7-9 hours consistently moves more healthspan markers than any supplement.
- Train 150+ min/week including resistance training matches or exceeds any single supplement effect.
- Mediterranean-style diet with adequate protein (1.6 g/kg/day) drives most cardiovascular and metabolic markers.
- Don't smoke; moderate alcohol has cohort effects larger than most supplements.
- Manage chronic stress (meditation, social support, adequate downtime).
The supplement layer is optimization on top of these behaviors. If the behaviors aren't in place, no supplement stack compensates. The most expensive supplement protocol with poor sleep loses to the boring four with 8 hours nightly.
See also
- Biohacking supplements guide for tier classification framework
- Longevity stack 2026 for the full sequenced protocol
- AMPK activators for the metabolic-pathway lens
- Senolytic supplements for the cellular-aging axis
- Beginners guide to healthspan for the lifestyle foundation
- Bloodwork tracker for tracking the biomarkers that matter
